The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]

W. Ingram*, N. C. Lea, J. Cervera, U. Germing, P. Fenaux, B. Cassinat, J. J. Kiladjian, J. Varkonyi, P. Antunovic, N. B. Westwood, M. J. Arno, A. Mohamedali, J. Gaken, T. Kontou, B. H. Czepulkowski, N. A. Twine, J. Tamaska, J. Csomer, S. Benedek, N. GattermannE. Zipperer, A. Giagounidis, Z. Garcia-Casado, G. Sanz, Ghulam J. Mufti

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

85 Citations (Scopus)
Original languageEnglish
Pages (from-to)1319-1321
Number of pages3
JournalLeukemia
Volume20
Issue number7
DOIs
Publication statusPublished - Jul 2006
Externally publishedYes

Cite this